You are not currently logged in.
Access JSTOR through your library or other institution:
Evaluation of the Effect of Treatment of Latent Tuberculosis Infection on QuantiFERON‐TB Gold Assay Results
Nira R. Pollock , MD, PhD, Suely S. Kashino , PhD, Danielle R. Napolitano , PhD, Alex Sloutsky , PhD, Swati Joshi , PhD, Jasmine Guillet , MPH, Michael Wong , MD, Edward Nardell , MD and Antonio Campos‐Neto , MD, PhD
Infection Control and Hospital Epidemiology
Vol. 30, No. 4 (April 2009), pp. 392-395
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/596606
Page Count: 4
You can always find the topics here!Topics: Tuberculin, Skin tests, Screening tests, Tuberculosis, Mycobacterium tuberculosis, Skin, Antigens, Latent tuberculosis, Occupational health services, Personnel evaluation
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
To evaluate the utility of the QuantiFERON‐TB Gold assay for monitoring latent tuberculosis treatment efficacy, the assay was performed serially for healthcare workers receiving isoniazid therapy. After 9 months of isoniazid therapy, all of these healthcare workers remained QuantiFERON‐TB Gold positive, and cellular proliferation assays revealed persistently strong purified protein derivative responses. These results do not support the use of the QuantiFERON‐TB Gold assay to monitor therapy.
© 2009 by The Society for Healthcare Epidemiology of America. All rights reserved.